OrganiGram (OGI)
(Real Time Quote from BATS)
$1.86 USD
-0.07 (-3.63%)
Updated Apr 25, 2024 03:08 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Income Statements
Fiscal Year end for Organigram Holdings Inc falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 120 | 115 | 115 | 62 | 65 |
Cost Of Goods | 92 | 90 | 90 | 85 | 107 |
Gross Profit | 28 | 25 | 25 | -22 | -42 |
Selling & Adminstrative & Depr. & Amort Expenses | 223 | 59 | 59 | 50 | 66 |
Income After Depreciation & Amortization | -195 | -34 | -34 | -72 | -108 |
Non-Operating Income | 8 | 23 | 23 | -28 | 4 |
Interest Expense | 0 | 0 | 0 | 2 | 4 |
Pretax Income | -187 | -11 | -11 | -103 | -109 |
Income Taxes | -3 | 0 | 0 | -8 | -8 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -184 | -11 | -11 | -103 | -101 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -184 | -11 | -11 | -103 | -101 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -176 | -14 | -14 | -48 | -95 |
Depreciation & Amortization (Cash Flow) | 19 | 20 | 20 | 24 | 13 |
Income After Depreciation & Amortization | -195 | -34 | -34 | -72 | -108 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 81.30 | 77.23 | 66.88 | 43.14 | 37.89 |
Diluted EPS Before Non-Recurring Items | -0.76 | -0.36 | -1.20 | -0.32 | 0.24 |
Diluted Net EPS (GAAP) | -2.27 | -0.16 | -0.14 | -1.61 | -2.35 |
Fiscal Year end for Organigram Holdings Inc falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 26.77 | 34.31 | 24.14 | 24.13 |
Cost Of Goods | NA | 21.85 | 27.74 | 27.59 | 27.59 |
Gross Profit | NA | 4.92 | 6.57 | -3.46 | -3.46 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 16.62 | 34.93 | 158.22 | 158.22 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -11.70 | -28.36 | -161.68 | -161.68 |
Non-Operating Income | NA | 0.17 | 1.02 | 3.64 | 3.64 |
Interest Expense | NA | 0.04 | 0.10 | 0.05 | 0.05 |
Pretax Income | NA | -11.57 | -27.32 | -158.08 | -158.08 |
Income Taxes | NA | 0.00 | -1.70 | -0.96 | -0.96 |
Minority Interest | NA | 0.00 | NA | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | NA | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | NA | 0.00 | 0.00 |
Income From Cont. Operations | NA | -11.57 | -25.62 | -157.15 | -157.12 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -11.57 | -25.62 | -157.15 | -157.12 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 81.19 | 314.20 | 315.29 | 89.02 |
Diluted EPS Before Non-Recurring Items | NA | -0.14 | -0.04 | -0.15 | -0.08 |
Diluted Net EPS (GAAP) | NA | -0.14 | -1.75 | -0.50 | -0.50 |